Abstract 391: Evolutionary trajectories and <i>KRAS</i> gene dosage define pancreatic cancer phenotypes
Sebastian Mueller(TUM Klinikum), Roland Rad(ING Direct), Magdalena Żukowska(German Cancer Research Center), Fengtang Yang(Shandong University of Technology), Julia Mayerle(LMU Klinikum), Wolfgang Enard(Ludwig-Maximilians-Universität München), Pentao Liu(Hong Kong Science and Technology Parks Corporation), Wilko Weichert(Deutsches Konsortium für Translationale Krebsforschung), Sandra Louzada(Wellcome Sanger Institute), Thomas Engleitner(Technical University of Munich), Kathleen Schuck(TUM Klinikum), Juliana Götzfried(TUM Klinikum), George S. Vassiliou(Wellcome/MRC Cambridge Stem Cell Institute), Roman Maresch(Technical University of Munich), Thorsten Kaltenbacher(Technical University of Munich), Christian Veltkamp(TUM Klinikum), Sebastian Lange(TUM Klinikum), Rupert Öllinger(Technical University of Munich), Alex Strong(Wellcome Sanger Institute), Kristian Unger(Helmholtz Zentrum München), Björn Konukiewitz(University Hospital Schleswig-Holstein), Swati Parekh(Ludwig-Maximilians-Universität München), Maximilian Zwiebel(Wellcome Sanger Institute), Beiyuan Fu(Wellcome Sanger Institute), Jorge de la Rosa(University of Cambridge), Sabine Klein(Friedrich-Loeffler-Institut), Barbara Seidler(German Cancer Research Center), Ignacio Varela(Wellcome Sanger Institute), Maxim Barenboim(German Cancer Research Center), Fernando Constantino‐Casas(University of Cambridge), Nina Schönhuber(Technical University of Munich), Hsi-Yu Yen(German Marine Research Consortium), Mario F. Fraga(Centre National de la Recherche Scientifique), Oliver M. Dovey(Wellcome Sanger Institute), Christoph Ziegenhain(Ludwig-Maximilians-Universität München), Zonera Hassan(TUM Klinikum), Ruby Banerjee(Wellcome Sanger Institute), Marta Sierra(Universidad de Oviedo), Allan Bradley(Granta Design (United Kingdom)), Günter Schneider(TUM Klinikum), Günter Klöppel(Technical University of Munich), Dieter Saur(German Cancer Research Center), Roland M. Schmid(Tumkur University), Stefan Eser(TUM Klinikum), Mathias Friedrich, Julia Hess(Helmholtz Munich), Katja Steiger(Technical University of Munich), Lena Rad(TUM Klinikum), Juan Cadiñanos(Universidad de Oviedo)
Cited by 0
Related Papers
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
|The Lancet|2005|3.4k